Antibody Discovery

Discover the efficiency of AbDrop™ & HUGO-Ab™ for rapid, fully human antibody discovery using microfluidics & TurboKnockout® technology in just 3 months.

Explore the role of TCR-like antibodies in targeting peptide-MHC complexes for precise cancer treatment, including development techniques and therapeutic applications.

Examine how antibody discovery drives CAR-T cell engineering, enhancing specificity, reducing toxicity, and advancing next-generation cancer immunotherapies.

Explore antibody discovery technologies like phage display, yeast display, & computational tools. Learn about trends in multi-specific antibodies & AI integration.

Explore the process of custom antibody development – from antigen design & immunization to production & characterization – for precise research & clinical applications.

Learn how in silico tools like SCM & TAP assess antibody developability, predicting properties like viscosity, immunogenicity & stability for therapeutic success.

Discover the evolution of antibody research, from Emil von Behring's diphtheria work to hybridoma technology and modern recombinant antibody advancements.